India's pharma stocks fall as Trump outlines steep tariffs on generic drug imports
22/07/2026 05:24
BUZZ-India's pharma stocks fall as Trump outlines steep tariffs on generic drug imports ** India's pharma stocks fall in morning trading
** U.S. President Donald Trump says imported generic drugs will remain tariff-free for two years from August 1, before tariffs increase to 100% for one year and 200% thereafter
** Nifty Pharma Index .NIPHARM down 1.01% amid a 0.7% decline in Nifty 50 Index .NSEI
** Shares of Aurobindo Pharma ARBN.NS down 2.9%, Sun Pharmaceutical SUN.NS down 1.2%, Cipla CIPL.NS down 2%, Lupin LUPN.NS falls 3%, Glenmark Pharmaceuticals GLEN.NS dips 2.6%
** Shares of Dr. Reddy's Laboratories REDY.NS fall 1.4%, Zydus Lifesciences ZYDU.NS down 2.4% and Torrent Pharmaceuticals TORP.NS down 0.8%
(Reporting by Abhinav Parmar in Bengaluru)
Recent news on Glenmark Pharmaceuticals
See all newsBrief: Glenmark Pharma Says Unit Launches Ryaltris Nasal Spray In Brazil For Allergic Rhinitis
Brief: Glenmark Pharma US Unit Launches Calcium Gluconate Injection USP In Multiple Vial Sizes
India's Glenmark Pharma gains most in three weeks on US approval for Flonase nasal spray
Brief: Glenmark Pharma Gets U.S. FDA Approval For Fluticasone Propionate Nasal Spray 0.05 Mg/Spray
India's Glenmark Pharmaceuticals falls as brokerage flags softer-than-expected quarter